ArticleACS catalysis2016
1,4-Dihydropyridines as Alkyl Radical Precursors: Introducing the Aldehyde Feedstock to Nickel/Photoredox Dual Catalysis.
Article in ACS catalysis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
60 citing papers in PubMed.
- The Preparation and Systematic Evaluation of Ligated Ni(II) Pre-Catalysts (NiPC) in Common Single Electron Cross-Coupling Reactions.ACS medicinal chemistry letters · 2026Article
- Biginelli dihydropyrimidines: a tunable class of alkyl radical precursors.Chemical science · 2026Article
- C-C Bond Formation via Direct Functionalization of Indolizines with a Bichromophoric Ruthenium Photocatalyst.ACS organic & inorganic Au · 2026Article
- Tackling the Reactivity of Propadiene: Palladium Metallaphotoredox Dual Catalyzed Multi-Component Allylation and Dienylation of Styrenes.Angewandte Chemie (International ed. in English) · 2026Article
- Photoinduced Cobalt-Catalyzed Reductive Coupling of Aryl Bromides and 1,4-Dihydropyridines.Chemistry, an Asian journal · 2026Article
- Electron donor-acceptor complex offers a diverse approach for carbonyl alkylative amination.Chemical science · 2025Article
- Article
- Access to quaternary-carbon-containing β-alkyl amidesRSC advances · 2025Article
- Cross-Coupling of Gaseous Alkanes with (Hetero)Aryl Bromides via Dual Nickel/Photoredox Catalysis.Angewandte Chemie (International ed. in English) · 2025Article
- Silyl Radicals as Single-Electron Reductants: α-Aminoalkyl Radical Formation via a Photocatalytic Oxidatively Initiated Radical Chain Process.Journal of the American Chemical Society · 2024Article
- Acyl-1,4-Dihydropyridines: Universal Acylation Reagents for Organic Synthesis.Molecules (Basel, Switzerland) · 2024Review
- Aromatization-driven deconstructive functionalization of spiro dihydroquinazolinonesChemical science · 2024Article
- 1,4-Dihydropyridine Anions as Potent Single-Electron Photoreductants.Organic letters · 2024Article
- Construction of 1,4-Dihydropyridines: The Evolution of C4 Source.Topics in current chemistry (Cham) · 2023Review
- Article
- ChemBeads-Enabled Photoredox High-Throughput Experimentation Platform to Improve C(spACS medicinal chemistry letters · 2023Article
- Exploiting photoredox catalysis for carbohydrate modification through C-H and C-C bond activation.Nature reviews. Chemistry · 2022Review
- Alkyl Radical Generation via C-C Bond Cleavage in 2-Substituted Oxazolidines.ACS catalysis · 2022Article
- Photocatalyst-free hydroacylations of electron-poor alkenes and enones under visible-light irradiation.Organic & biomolecular chemistry · 2022Article
- Dihydroquinazolinones as adaptative C(spNature communications · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
A Ni/photoredox dual catalytic cross-coupling is disclosed in which a diverse range of (hetero)aryl bromides are used as electrophiles, with 1,4-dihydropyridines serving as precursors to C
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.